vTv Therapeutics appoints Paul Sekhri to its Board as CEO

– USA, NC –  vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company today announced the appointment of Paul Sekhri to its Board of Directors as President and CEO, effective August 1, 2022.…